Sort
27,075 grants matching “cholesterol”
New Approaches to Reduce Residual Cardiovascular Risk
$2,484,600Jay D Horton · Ut Southwestern Medical Center · P01 · FY2023 · HL
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
$2,482,205Jan Johansson · Artery Therapeutics, Inc. · R44 · FY2023 · AG
Role of O-glycosylation in Animal Development
$2,477,620Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Contraceptive Discovery, Development and Behavioral Research Center
$2,473,290Gunda I. Georg · University Of Minnesota · U54 · FY2017 · HD
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,467,924M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Cardiovascular Disease and Diabetes Program Project
$2,466,716Karin E. Bornfeldt · University Of Washington · P01 · FY2017 · HL
Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms
$2,464,111Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Oxidative Modification Of Proteins
$2,457,717Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Endocannabinoids And Energy Homeostasis
$2,457,470George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chronic toxicology studies in Wistar rats and Cynomolgus monkeys
$2,454,521Jan Johansson · Artery Therapeutics, Inc. · R44 · FY2025 · AG
Triglycerides, Diabetes and Cardiovascular Disease
$2,453,240Karin E. Bornfeldt · University Of Washington · P01 · FY2024 · HL
National Health and Nutrition Examination Survey (NHANES), Cardiovascular, Pulmonary, Vascular and Sleep Component
$2,449,000National Heart, Lung, And Blood Institute · Y01 · FY2022 · HL
Cell and Molecular Pathobiology of Alzheimer's Disease
$2,443,714Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2017 · AG
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes
$2,441,919Chad Albert Cowan · Massachusetts General Hospital · U01 · FY2014 · HL
National Health and Nutrition Examination Survey (NHANES), Cardiovascular, Pulmonary, Vascular and Sleep Component
$2,435,000National Heart, Lung, And Blood Institute · Y01 · FY2021 · HL
New Approaches to Reduce Residual Cardiovascular Risk
$2,434,908Jay D Horton · Ut Southwestern Medical Center · P01 · FY2024 · HL
Multidisciplinary Approaches to HDL Structure, Assembly and Function
$2,432,193Jere P Segrest · Vanderbilt University Medical Center · P01 · FY2017 · HL
Wadsworth Center's Children's Health Exposure Assessment Resource (WC-CHEAR)
$2,431,534Patrick Jeremy Parsons · Wadsworth Center · U2C · FY2018 · ES
Cell and Molecular Pathobiology of Alzheimer's Disease
$2,430,420Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2019 · AG
Cell and Molecular Pathobiology of Alzheimer's Disease
$2,430,420Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2018 · AG
Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase I
$2,429,633Roberta Diaz Brinton · University Of Southern California · UF1 · FY2013 · AG
Disease Model Development and Phenotyping Project
$2,427,950Gareth R Howell · Indiana University Indianapolis · U54 · FY2018 · AG
Vascular Biology: Exercise Training and Vascular Disease
$2,427,759M Harold Laughlin · University Of Missouri-Columbia · P01 · FY2010 · HL
Cell and Molecular Pathobiology of Alzheimer's Disease
$2,426,988Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2020 · AG
Oxidative Modification Of Proteins
$2,426,516Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL